Dimethyloleuropein.

Demethyloleuropein and oleuropein are the two dominant secoiridoid glucosides of olive fruit, and the balance between them shifts toward the demethylated form as the fruit ripens. They share a hydrolysis route and a common end product. An extract assayed only to oleuropein does not tell you how much of the related secoiridoid pool it carries.

Colonic bacteria carry the beta-glucosidase activity that releases the aglycone from secoiridoid glucosides that escape upper gut absorption. Which species are present therefore shapes how much phenol is liberated. This is a genuine source of person-to-person variation in what a fixed dose produces.

Ascorbate regenerates oxidised catechol phenols back to their reduced form, and olive phenols are catechols. The pairing is measured on redox markers in solution and in plasma. A marker moving is not the same as a clinical outcome, and no endpoint follows from this pairing alone.

Olive phenols sit in the aqueous phase and tocopherols in membranes, and the two exchange reducing equivalents at the interface. Whole olive oil delivers both together, which is the natural version of this pairing. It is a mechanistic rationale rather than a demonstrated combined effect.

The glucoside form is water soluble but the hydrolysed aglycone is lipophilic, and a lipid vehicle keeps it dispersed and moving with the fat phase. This is how olive oil delivers the same phenols in the diet. The vehicle affects delivery, not the underlying chemistry.

Catechol groups bind ferric iron avidly, which is the basis of the well-known polyphenol effect on non-heme iron absorption. A phenol-rich olive extract taken with an iron dose will lower how much of that iron is taken up. Separating the two by a couple of hours avoids the issue.

Catechols chelate copper as well as iron, and copper-phenol complexes can behave as pro-oxidants under some conditions rather than antioxidants. This is one reason concentrated phenol dosing is not simply better than food-level intake. The context determines which direction the chemistry runs.

Both are handled by intestinal and hepatic sulfotransferases and UDP-glucuronosyltransferases, and that conjugation capacity is finite. Large simultaneous doses of two polyphenols compete for the same enzymes, which raises the unconjugated fraction of each. The interaction is on metabolism, not on any shared target.

Catechins and olive secoiridoids run through the same glucuronidation and sulfation route. Stacking two concentrated polyphenol extracts saturates that capacity rather than doubling the benefit. Both also bind non-heme iron, so the mineral effect compounds too.

Release of the active phenol requires ester and glycoside bond cleavage, work done by endogenous esterases, beta-glucosidase and the microbiota. Supplemental enzyme blends rarely contain the specific beta-glucosidase activity needed. The mechanistic logic is sound but the practical match between blend and bond is often absent.

Squalane is another olive-derived material and shows up alongside olive phenols in topical formulation, where it acts as the lipid carrier. The pairing is a formulation convention drawn from a shared source plant. It says nothing about oral activity.